SEC Filing

View:

SEC FORM 4/A SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

KUESTER DENNIS J

(Last)

(First)

(Middle)

4900 WEST BROWN DEER ROAD

(Street)

MILWAUKEE

53223

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Metavante Technologies, Inc. [ MV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/01/2007

4. If Amendment, Date of Original Filed (Month/Day/Year)
11/05/2007

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$14.69⁽¹⁾⁽²⁾	11/01/2007		A		176,388⁽¹⁾⁽²⁾		12/10/1998	12/10/2008	Common Stock	176,388⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	176,388⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$14.69⁽¹⁾⁽²⁾	11/01/2007		D			132,291⁽¹⁾⁽²⁾	12/10/1998	12/10/2008	Common Stock	132,291⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	44,097⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$17.44⁽¹⁾⁽²⁾	11/01/2007		A		245,179⁽¹⁾⁽²⁾		12/16/1999	12/16/2009	Common Stock	245,179⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	245,179⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$17.44⁽¹⁾⁽²⁾	11/01/2007		D			183,885⁽¹⁾⁽²⁾	12/16/1999	12/16/2009	Common Stock	183,885⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	61,294⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$12.93⁽¹⁾⁽²⁾	11/01/2007		A		282,221⁽¹⁾⁽²⁾		12/14/2000	12/14/2010	Common Stock	282,221⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	282,221⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$12.93⁽¹⁾⁽²⁾	11/01/2007		D			211,666⁽¹⁾⁽²⁾	12/14/2000	12/14/2010	Common Stock	211,666⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	70,555⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$18.12⁽¹⁾⁽²⁾	11/01/2007		A		432,151⁽¹⁾⁽²⁾		12/20/2001	12/20/2011	Common Stock	432,151⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	432,151⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$18.12⁽¹⁾⁽²⁾	11/01/2007		D			324,114⁽¹⁾⁽²⁾	12/20/2001	12/20/2011	Common Stock	324,114⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	108,037⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$16.19⁽¹⁾⁽²⁾	11/01/2007		A		476,248⁽¹⁾⁽²⁾		10/25/2002	10/25/2012	Common Stock	476,248⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	476,248⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$16.19⁽¹⁾⁽²⁾	11/01/2007		D			357,186⁽¹⁾⁽²⁾	10/25/2002	10/25/2012	Common Stock	357,186⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	119,062⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$19.73⁽¹⁾⁽²⁾	11/01/2007		A		357,186⁽¹⁾⁽²⁾		10/27/2003	10/27/2013	Common Stock	357,186⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	357,186⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$19.73⁽¹⁾⁽²⁾	11/01/2007		D			267,890⁽¹⁾⁽²⁾	10/27/2003	10/27/2013	Common Stock	267,890⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	89,296⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$23.79⁽¹⁾⁽²⁾	11/01/2007		A		357,186⁽¹⁾⁽²⁾		10/27/2004	10/27/2014	Common Stock	357,186⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	357,186⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$23.79⁽¹⁾⁽²⁾	11/01/2007		D			267,890⁽¹⁾⁽²⁾	10/27/2004	10/27/2014	Common Stock	267,890⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	89,296⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$24.28⁽¹⁾⁽²⁾	11/01/2007		A		357,186⁽¹⁾⁽²⁾		10/28/2005	10/28/2015	Common Stock	357,186⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	357,186⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$24.28⁽¹⁾⁽²⁾	11/01/2007		D			267,890⁽¹⁾⁽²⁾	10/28/2005	10/28/2015	Common Stock	267,890⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	89,296⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$27.26⁽¹⁾⁽²⁾	11/01/2007		A		321,467⁽¹⁾⁽²⁾		10/30/2006	10/30/2016	Common Stock	321,467⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	321,467⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$27.26⁽¹⁾⁽²⁾	11/01/2007		D			241,101⁽¹⁾⁽²⁾	10/30/2006	10/30/2016	Common Stock	241,101⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	80,366⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$23.79⁽¹⁾⁽²⁾	11/01/2007		A		264,582⁽¹⁾⁽²⁾		10/19/2007	10/19/2017	Common Stock	264,582⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	264,582⁽¹⁾⁽²⁾	D
Stock Option (right to buy)	$23.79⁽¹⁾⁽²⁾	11/01/2007		D			198,437⁽¹⁾⁽²⁾	10/19/2007	10/19/2017	Common Stock	198,437⁽¹⁾⁽²⁾	⁽¹⁾⁽²⁾	66,145⁽¹⁾⁽²⁾	D

Explanation of Responses:

1. In connection with the merger of one of the issuer's subsidiaries into Marshall & Ilsley Corporation ("Old Marshall & Ilsley") to effect the formation of a holding company (the "Holding Company Merger"), the separation of Old Marshall & Ilsley from Metavante Corporation and related transactions, the Reporting Person's outstanding Old Marshall & Ilsley stock option was converted into an option to acquire Metavante Technologies, Inc. ("Metavante") common stock. The number of stock options held by the Reporting Person, and their exercise price, were adjusted pursuant to the Employee Matters Agreement, dated April 3, 2007, as amended, that was executed in connection with the separation transaction. The adjustment was implemented in a manner that preserved the intrinsic value of each option on the closing date.

2. Pursuant to the Employee Matters Agreement that was executed in connection with the separation transaction, 25% of the Reporting Person's Old Marshall & Ilsley stock options were converted into Metavante stock options and 75% of such options were converted into New Marshall & Ilsley Corporation stock options. The disposition reported in the table gives effect to the 25%/75% split discussed above.

Remarks:

The purpose of this amendment is to update the number of stock options held by the Reporting Person, and their exercise price, based on the actual adjustment ratios. The amounts set forth in the previous Form 4 were estimates, since pursuant to the Employee Matters Agreement the number of stock options, and their exercise price, were not determinable until the close of trading on the New York Stock Exchange on November 15, 2007.

	/s/ Stacey Bruckner, as Attorney-in-Fact	11/19/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.